![engineer](https://www.expertmarketresearch.com/assets/image/reports/user-blue-new.webp)
Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Base Year
Historical Year
Forecast Year
The key features of the market report include patent analysis, grants analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
Roche Holding AG
F. Hoffmann-La Roche AG, a Swiss multinational holding healthcare company, has Mabthera/Rituxan (rituximab) drug which is FDA-approved for two rare forms of vasculitis including granulomatosis with polyangiitis.
GlaxoSmithKline plc (GSK)
This British multinational pharmaceutical and biotechnology company is a prominent market player and has received regulatory approval to market its drug candidate Nucala (mepolizumab) for targeted treatment of eosinophilic granulomatosis with polyangiitis (EGPA).
Pfizer Inc.
Pfizer Inc. is a key market player and actively invests in research and development of innovative treatments. Its RUXIENCE® (rituximab-pvvr) injection is indicated for granulomatosis with polyangiitis in adult patients in combination with glucocorticoids.
Sanofi
Sanofi is an innovative global healthcare company with a robust market presence. It is involved in the clinical development of new therapeutic treatments for rare diseases.
Other players in the market include Bristol Myers Squibb, Novartis AG, AbbVie Inc., Amgen Inc., Johnson & Johnson, and AstraZeneca plc.
North America Granulomatosis with Polyangiitis Treatment Market Size
North America Granulomatosis with Polyangiitis Treatment Market Analysis
North America Granulomatosis with Polyangiitis Treatment Companies
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
The North America granulomatosis with polyangiitis treatment market is expected to be driven by the rising demand for the global market, which is anticipated to grow at a CAGR of 4.90% during the forecast period of 2025-2034.
The increasing healthcare expenditure and the rising advancements in personalized medicine are fuelling the demand for the market.
One of the significant trends in the market is the increased entry of high-quality biosimilars indicated for granulomatosis with polyangiitis. In July 2023, Dr. Reddy's Laboratories Ltd., announced that the biologics license application (BLA) for its proposed rituximab biosimilar (DRL_RI) was accepted for a substantive review by the FDA.
Based on the drug class, the market is segmented into steroids and immunosuppressant.
By route of administration, the market is divided into oral and intravenous.
Distribution channels of the market are hospital pharmacies, retail pharmacies, and online pharmacies.
The market segmentation by countries includes the United States and Canada.
The key players in the market are Roche Holding AG, GlaxoSmithKline plc (GSK), Pfizer Inc., Sanofi, Bristol Myers Squibb, Novartis AG, AbbVie Inc., Amgen Inc., Johnson & Johnson, and AstraZeneca plc.
Datasheet
One User
USD 2,699
USD 2,429
tax inclusive*
Single User License
One User
USD 4,299
USD 3,869
tax inclusive*
Five User License
Five User
USD 5,799
USD 4,949
tax inclusive*
Corporate License
Unlimited Users
USD 6,999
USD 5,949
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124